Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | TYR | P14679 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8142070 | 0.80 | CA2 (0.32) | CA1CA2CA9 | |
| SCHEMBL7796642 | 0.78 | CYP3A4 (0.53) | MAPTRAB9AALDH1A1NPC1SMN1; SMN2 | |
| SCHEMBL2090987 | 0.77 | ACACB (0.38) | MAPTTSHRMEN1KMT2AKIF11 | |
| SCHEMBL7779083 | 0.77 | TSHR (0.39) | TSHR | |
| SCHEMBL513896 | 0.77 | CA1 (0.48) | CA1CA2CA9ALDH1A1TSHR | |
| SCHEMBL6720151 | 0.77 | MAPT (0.47) | CA1CA2CA9MAPTRAB9A | |
| SCHEMBL17248023 | 0.77 | MAPT (0.47) | CA1CA2CA9MAPTRAB9A | |
| SCHEMBL2090940 | 0.74 | CA1 (0.33) | CA1CA2CA9KIF11 | |
| SCHEMBL96667 | 0.73 | CA1 (0.58) | CA1CA2CA9MAPTRAB9A | |
| SCHEMBL95901 | 0.73 | ACHE (0.48) | CA1CA2CA9MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1539 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5234930-A | Treating psychological, cardiovascular, urogenital and respiratory disorders; diabetes, asthmas, sudden infant death syndrome | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-08-10 | — | — | US | claimed |
| EP-0354297-B1 | THIADIAZINES, PROCESS FOR PRODUCTION THEREOF, AND INSECTICIDAL AND ACARICIDAL AGENTS COMPRISING THE THIADIAZINES | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1992-08-05 | — | — | EP | claimed |
| CN-118202006-A | Resin composition, cured product, optical member, ultraviolet absorber, compound, method for producing compound, and polymer | 富士胶片株式会社 | 2024-06-14 | — | — | CN | disclosed |
| CN-118176445-A | Light absorbing filter, light filter, method for manufacturing light absorbing filter, organic electroluminescent display device, inorganic electroluminescent display device, and liquid crystal display device | 富士胶片株式会社 | 2024-06-11 | — | — | CN | disclosed |
| US-11993697-B2 | Flexible tube for endoscope, endoscopic medical device, and resin composition for covering flexible tube substrate for endoscope | FUJIFILM CORPORATION (JP) | 2024-05-28 | — | — | US | disclosed |
| US-11958959-B2 | Lens for spectacles and spectacles | FUJIFILM CORPORATION (JP) | 2024-04-16 | — | — | US | disclosed |
| WO-2024062843-A1 | COLORED COMPOSITION, COLORED PRODUCT, AND COMPOUND | 富士フイルム株式会社 | 2024-03-28 | — | — | WO | disclosed |
| US-20240084106-A1 | KNEADED MATERIAL, METHOD OF PRODUCING KNEADED MATERIAL, MOLDED BODY, AND OPTICAL MEMBER | FUJIFILM CORPORATION (JP) | 2024-03-14 | — | — | US | disclosed |
| EP-3646770-B1 | ENDOSCOPE FLEXIBLE TUBE, ENDOSCOPE-TYPE MEDICAL DEVICE, RESIN COMPOSITION FOR COATING ENDOSCOPE FLEXIBLE-TUBE SUBSTRATE, AND RESIN COMPOSITION SET FOR COATING ENDOSCOPE FLEXIBLE-TUBE SUBSTRATE | FUJIFILM CORP (JP) | 2024-03-13 | — | — | EP | disclosed |
| US-20240067846-A1 | PHOTOPOLYMERIZABLE COMPOSITION, CURED SUBSTANCE, AND OPTICAL MEMBER | FUJIFILM CORPORATION (JP) | 2024-02-29 | — | — | US | disclosed |
| US-20240051916-A1 | METHOD FOR PRODUCING N-(HETERO)ARYL (METH)ACRYLAMIDE COMPOUND | FUJIFILM CORPORATION (JP) | 2024-02-15 | — | — | US | disclosed |
| EP-0272583-A2 | 5-Substituted amino-4-hydroxy-pentenoic acid derivatives and their use | Banyu Pharmaceutical Co., Ltd. (JP) | 1988-06-29 | — | — | EP | disclosed |
| EP-0264106-A2 | 5-Substituted amino-4-hydroxy-pentanoic acid derivatives and their use | Banyu Pharmaceutical Co., Ltd. (JP) | 1988-04-20 | — | — | EP | disclosed |
| US-4652648-A | STABILIZERS FOR HEAT, OXIDATION AND LIGHT | CIBA-GEIGY CORPORATION (US) | 1987-03-24 | — | — | US | disclosed |
| US-4579682-A | HEAT, OXYGEN, AND LIGHT PROTECTION FOR POLYMERS | CIBA-GEIGY CORPORATION (US) | 1986-04-01 | — | — | US | disclosed |
| US-4434109-A | STABILIZERS AGAINST HEAT, OXYGEN AND LIGHT | CIBA-GEIGY CORPORATION (US) | 1984-02-28 | — | — | US | disclosed |
| US-4283523-A | MODIFIED BY A FLUORO ALIPHATIC ALCOHOL | HOOKER CHEMICALS & PLASTICS CORP. (US) | 1981-08-11 | — | — | US | disclosed |
| US-4259350-A | PROTECTING DEGRADABLE ORGANIC MATERIAL FROM FUNGAL OR INSECT ATTACK | SANKYO COMPANY LIMITED (JP) | 1981-03-31 | — | — | US | disclosed |
| US-4255301-A | HEAT RESISTANCE, PHOTOSTABILITY | ARGUS CHEMICAL CORPORATION (US) | 1981-03-10 | — | — | US | disclosed |
| EP-0021653-A1 | Linear aromatic polyesters of enhanced hydrolytic stability, their preparation and shaped articles thereof | HOOKER CHEMICALS & PLASTICS CORP. (US) | 1981-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240051916-A1 | METHOD FOR PRODUCING N-(HETERO)ARYL (METH)ACRYLAMIDE COMPOUND | NAT1, AHR, PAM | CA1 4202/4885CA2 3603/4885CA9 3288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.